Bringing you the Best Analytical Legal News
The book running lead managers of this IPO were IIFL Capital Services Limited (formerly known as IIFL Securities Limited), CLSA India Private Limited and Systematix Corporate Services Limited.
The proceeds of the financing were primarily used by the Issuer to fund part of the consideration for its acquisition of Micro Biopharm Japan Company Limited in Japan.
The transaction is India’s first “blue financing” in the maritime sector and the first such blue-finance deal for port infrastructure in the Asia-Pacific region. It also represents the first investment by a multilateral finance institution in an Indian major port, with JNPA set to become the first Indian port to deploy shore power technology at a commercial scale.
S. Vivek has over 16 years of experience across capital markets, strategic transactions, and financial and securities regulation. His capital markets practice spans across IPOs, rights issues, qualified institutions placements, ADRs, preferential allotments, acting for both the issuers and lead managers.
Cyril Amarchand Mangaldas advised Linux Laboratories Private Limited on the acquisition of a stake by ChrysCapital and Tata Capital Healthcare Fund III, alongside the exit of Tata Capital Healthcare Fund II.
The Oxane Partners group is engaged in the business of providing technology-enabled solutions for private credit markets.
The transaction values Lynks at INR 500 crores and is expected to strengthen Udaan’s presence across key consumption markets in India.
The buyback is being undertaken from all eligible shareholders on a proportionate basis through the tender offer route, at a price of INR 1,450 per equity share, payable in cash, for an aggregate amount not exceeding INR 300,00,00,000.
This would mark CPP Investments’ first direct investment in India’s hospitality sector and will support expansion of the hospitality platform.
In this conversation, Manmeet Singh, Partner at Cyril Amarchand Mangaldas, discusses how dispute resolution clauses are negotiated, controlling costs in high value
The BRLMs were JM Financial Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited) and Morgan Stanley India Company Private Limited.
CAM advised on all aspects of the Transaction, including the legal due diligence and the transaction documents.
The team was led by Gokul Rajan, Partner (Regional Co-Head – Capital Markets – North); with the support from Adwait Deshmukh, Senior Associate; and Archit Jain, Associate.
The Transaction is expected to close in Q1 2027, subject to receipt of required regulatory approvals and satisfaction of other customary closing conditions.
This is the second largest IPO in India by India’s largest stock exchange and the world’s largest multi asset class exchange. The issue size was INR 226 billion (approximately USD 2.36 billion).
The Firm also advised the Selling Shareholders namely, O P Munjal Holdings Limited and Hero Cycles Limited on their participation in the offer for sale component of the Offer.
The transaction was led by Aashima Johur, Partner; with support from Medhashree Verma, Senior Associate.
The investment is intended to support the development and construction of ACME’s pipeline of green molecule projects across India and the Middle East, underpinning the next phase of growth of its energy transition business.
The book running lead managers to the Offer were Motilal Oswal Investment Advisors Limited, Axis Capital Limited and IIFL Capital Services Limited (formerly known as IIFL Securities Limited).
Cyril Amarchand Mangaldas advised Centella Mauritius Holdings Limited, a TPG backed special purpose investment vehicle, with respect to the sale of equity shares of Aster DM Quality Care Limited